SCHEMBL4501664

SCHEMBL4501664

CCCC(=O)N(CCN(C)C)c1ccc(N/C(=C2\C(=O)Nc3cc(Cl)ccc32)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.35
LIMK1 P53667 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
PLK1 P53350 1/20 0.34
TERT O14746 1/20 0.33
POLB P06746 1/20 0.33
MAPK8 P45983 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CES1 P23141 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501665 1.00 TP53 (0.40) TP53LTB4R2LIMK1MEN1KMT2A
SCHEMBL4496690 0.93 LIMK1 (0.36) LIMK1MEN1KMT2APLK1MAPK8
SCHEMBL4496696 0.93 LIMK1 (0.36) LIMK1MEN1KMT2APLK1MAPK8
SCHEMBL4481348 0.90 TP53 (0.40) TP53LTB4R2MEN1KMT2AMAPT
SCHEMBL4481354 0.90 TP53 (0.40) TP53LTB4R2MEN1KMT2AMAPT
SCHEMBL4488268 0.90 KDM4E (0.36) LIMK1MEN1KMT2APLK1POLB
SCHEMBL4488264 0.90 KDM4E (0.36) LIMK1MEN1KMT2APLK1POLB
SCHEMBL4491553 0.90 LIMK1 (0.37) LIMK1PLK1POLBMAPK8TMEM97
SCHEMBL4491548 0.90 LIMK1 (0.37) LIMK1PLK1POLBMAPK8TMEM97
SCHEMBL4491348 0.90 LIMK1 (0.37) TP53LIMK1PLK1ALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR TP53 681/4885LTB4R2 1491/4885LIMK1 312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.